Lazard Asset Management
TCRT icon

Lazard Asset Management’s Alaunos Therapeutics TCRT Stock Holding History

Lazard Asset Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-261
Closed -$19K – 2474
2023
Q2 		$19K Buy
261
+7
+3% +$510 ﹤0.01% 2108
2023
Q1 		$23K Buy
254
+169
+199% +$15.3K ﹤0.01% 2030
2022
Q4 		$8K Buy
+85
New +$8K ﹤0.01% 2222